Our motivation to combine Rb inactivation with Brca1 and p53 mutation derives, in part, from the observation that the Rb gene is among the most frequently deleted loci in Brca1/p53-mutated mouse tumors [22], indicating that Rb is a critical barrier to tumor progression. The gene discussed is RB1; the disease is neoplasm.